PLATFORM

Building the Operating system for Precision immune medicine

The integration of technologies that enhance identification, stratification and predictive capabilities around personalized immunotherapies

Continued advances in cell biology combined with access to broad multiomics data sets have shifted disease treatment from mass-market drugs to personalized precision medicines. We are taking this one step further to precision immune medicine, where we seek to harness the body’s own immune system to create safe cures for solid tumor cancers. Our technology platform vastly reshapes the discovery and development process by using multidimensional data that includes target, treatment, and patient selection to predict what treatments will work for specific patient groups.

OUR PLATFORM RESOURCES:

  • Unique patient and tumor data
  • Science & molecular libraries
  • Modality and therapy applications
  • Highly differentiated integration of all data to drive unique insights and vastly enhance predictive capabilities

THE POWER OF DATA

Using integrated, multidimensional patient data helps us design safe and effective treatments. This approach can assist in target and therapeutic modality selection, as well as identifying patients for stratified clinical trials, reducing the number of participants and the cost of trials.

The power of patient data

DIVE DEEPER

Learn more about how the Javelin Oncology platform integrates multidimensional data and sophisticated prediction methods to enhance identification, stratification and predictive capabilities around personalized immunotherapies

Methodology

Learn how we use multidimensional data to inform target design

Validation

Using our proprietary models and algorithms to predict clinical response rates

Open Access

Versatile platform shared with others to advance and accelerate their immuno-oncology applications

LEARN MORE ABOUT THE JAVELIN PLATFORM